Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02053285 · ClinicalTrials.gov registry record
Pilot Study of a Novel Type of CT Scan to Assess Treatment Response During Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 9
- Enrollment target
NCT02053285 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT02053285 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Dual-energy CT (DECT) provides information on the blood volume in tumors and lymph nodes. As tumors respond to treatment, preliminary data suggests that the blood volumes changes as well. Investigators are therefore using DECT to test whether it can be used on radiation treatment to rapidly assess response to treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-01 |
| Est. Completion | 2020-02-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02053285
The ClinicalTrials.gov registry entry for NCT02053285 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02053285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02053285 about?
NCT02053285 is a clinical study titled "Pilot Study of a Novel Type of CT Scan to Assess Treatment Response During Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer". Dual-energy CT (DECT) provides information on the blood volume in tumors and lymph nodes. As tumors respond to treatment, preliminary data suggests that the blood volumes changes as well. Investigators are therefore using DECT to test whether it can be used on radiation treatment to rapidly assess r...
What is the current status of trial NCT02053285?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2014-01. Estimated completion is 2020-02-20.
Who is sponsoring clinical trial NCT02053285?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.